Dysfunction of cardiac ryanodine receptors in the metabolic syndrome

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 108-114

  Dincer, U Deniz ^a   Araiza, Alberto ^a   Knudson, Jarrod D ^a   Shao, Chun Hong ^b   Bidasee, Keshore R ^b   Tune, Johnathan D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

"Leaky" RyR2; Heart; Prediabetic metabolic syndrome; Ryanodine receptor; RyR2 Ser2809 phosphorylation

Indexed keywords

HEART RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; RYANODINE; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOG; EXERCISE; FEMALE; GENE EXPRESSION; HEART DISEASE; HEART INDEX; HEART LEFT VENTRICLE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; WESTERN BLOTTING;

ANIMALS; CELL MEMBRANE STRUCTURES; DOGS; FEMALE; MALE; METABOLIC SYNDROME X; MYOCARDIUM; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SERINE;

CANIS FAMILIARIS;

EID: 33745345185     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.04.018     Document Type: Article

References (49)

1. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
2. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
3. Hansen B.C. The metabolic syndrome X. Ann N Y Acad Sci 892 (1999) 1-24
4. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
5. Henry P., Thomas F., Benetos A., and Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 40 (2002) 458-463
6. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 288 (2002) 2709-2716
7. Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001) 225-236
8. Alpert M.A., Fraley M.A., Birchem J.A., and Senkottaiyan N. Management of obesity cardiomyopathy. Expert Rev Cardiovasc Ther 3 (2005) 225-230
9. Kasper E.K., Hruban R.H., and Baughman K.L. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol 70 (1992) 921-924
10. Koch R., and Sharma A.M. Obesity and cardiovascular hemodynamic function. Curr Hypertens Rep 1 (1999) 127-130
11. Cabrol P., Galinier M., Fourcade J., Verwaerde P., Massabuau P., Tran M.A., et al. Functional decoupling of left ventricular beta-adrenoceptor in a canine model of obesity-hypertension. Arch Mal Coeur Vaiss 91 (1998) 1021-1024
12. Carroll J.F., Jones A.E., Hester R.L., Reinhart G.A., Cockrell K., and Mizelle H.L. Reduced cardiac contractile responsiveness to isoproterenol in obese rabbits. Hypertension 30 (1997) 1376-1381
13. Hall J.E., Brands M.W., Zappe D.H., Dixon W.N., Mizelle H.L., Reinhart G.A., et al. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension 25 (1995) 994-1002
14. Setty S., Sun W., and Tune J.D. Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 98 (2003) 416-423
15. Houser S.R., and Margulies K.B. Is depressed myocyte contractility centrally involved in heart failure?. Circ Res 92 (2003) 350-358
16. Scoote M., and Williams A.J. The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res 56 (2002) 359-372
17. Knudson J.D., Dincer U.D., Dick G.M., Shibata H., Akahane R., Saito M., et al. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol, Heart Circ Physiol 289 (2005) H1038-H1046
18. Zhang C., Knudson J.D., Setty S., Araiza A., Dincer U.D., Kuo L., et al. Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol, Heart Circ Physiol 288 (2005) H2154-H2162
19. Guner S., Arioglu E., Tay A., Tasdelen A., Aslamaci S., Bidasee K.R., et al. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem 263 (2004) 143-150
20. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
21. Bidasee K.R., Dincer U.D., and Besch Jr. H.R. Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats. Mol Pharmacol 60 (2001) 1356-1364
22. Bidasee K.R., Nallani K., Yu Y., Cocklin R.R., Zhang Y., Wang M., et al. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52 (2003) 1825-1836
23. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
24. Bidasee K.R., Nallani K., Besch Jr. H.R., and Dincer U.D. Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305 (2003) 989-998
25. de la Maza M.P., Estevez A., Bunout D., Klenner C., Oyonarte M., and Hirsch S. Ventricular mass in hypertensive and normotensive obese subjects. Int J Obes Relat Metab Disord 18 (1994) 193-197
26. Scaglione R., Dichiara M.A., Indovina A., Lipari R., Ganguzza A., Parrinello G., et al. Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 13 (1992) 738-742
27. Hohl C.M., Hu B., Fertel R.H., Russell J.C., McCune S.A., and Altschuld R.A. Effects of obesity and hypertension on ventricular myocytes: comparison of cells from adult SHHF/Mcc-cp and JCR:LA-cp rats. Cardiovasc Res 27 (1993) 238-242
28. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
29. Fagius J. Sympathetic nerve activity in metabolic control-Some basic concepts. Acta Physiol Scand 177 (2003) 337-343
30. Grassi G., Dell'Oro R., Quarti-Trevano F., Scopelliti F., Seravalle G., Paleari F., et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48 (2005) 1359-1365
31. Carroll J.F. Post-beta-receptor defect in isolated hearts of obese-hypertensive rabbits. Int J Obes Relat Metab Disord 23 (1999) 863-866
32. Lehnart S.E., Wehrens X.H., Laitinen P.J., Reiken S.R., Deng S.X., Cheng Z., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214
33. Lehnart S.E., Wehrens X.H., and Marks A.R. Defective ryanodine receptor interdomain interactions may contribute to intracellular Ca2+ leak: a novel therapeutic target in heart failure. Circulation 111 (2005) 3342-3346
34. Ono K., Yano M., Ohkusa T., Kohno M., Hisaoka T., Tanigawa T., et al. Altered interaction of FKBP12.6 with ryanodine 23 receptor as a cause of abnormal Ca(2+) release in heart failure. Cardiovasc Res 48 (2000) 323-331
35. Wehrens X.H., Lehnart S.E., Reiken S., Vest J.A., Wronska A., and Marks A.R. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A 103 (2006) 511-518
36. Yano M., Kobayashi S., Kohno M., Doi M., Tokuhisa T., Okuda S., et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107 (2003) 477-484
37. Bers D.M., Eisner D.A., and Valdivia H.H. Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ Res 93 (2003) 487-490
38. Li Y., Kranias E.G., Mignery G.A., and Bers D.M. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90 (2002) 309-316
39. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
40. Song L.S., Wang S.Q., Xiao R.P., Spurgeon H., Lakatta E.G., and Cheng H. beta-Adrenergic stimulation synchronizes intracellular Ca(2+) release during excitation-contraction coupling in cardiac myocytes. Circ Res 88 (2001) 794-801
41. Valdivia H.H., Kaplan J.H., Ellis-Davies G.C., and Lederer W.J. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science 267 31 (1995 Mar) 1997-2000
42. Viatchenko-Karpinski S., and Gyorke S. Modulation of the Ca(2+)-induced Ca(2+) release cascade by beta-adrenergic stimulation in rat ventricular myocytes. J Physiol 533 15 (2001 Jun) 837-848
43. Stange M., Xu L., Balshaw D., Yamaguchi N., and Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem 19 278 (2003 Dec) 51693-51702
44. Xiao B., Sutherland C., Walsh M.P., and Chen S.R. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res 94 5 (2004 Mar) 487-495
45. Dincer U.D., Araiza A.G., Varela J., Williams K.C., Molina P.E., and Tune J.D. Alpha-1-adrenoceptor-mediated coronary vasoconstriction is enhanced in the prediabetic metabolic syndrome. Circulation 112 (2005) II66-II67 [Abstract]
46. Taur Y., and Frishman W.H. The cardiac ryanodine receptor (RyR2) and its role in heart disease. Cardiol Rev 13 (2005) 142-146
47. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 (2005) 25-35
48. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 28 (2000) 1685-1696
49. Bidasee K.R., Zhang Y., Shao C.H., Wang M., Patel K.P., Dincer U.D., et al. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 53 (2004) 463-473